Aqur Biosciences

Funding and NIH signals

• SEC Form D raise Raised $1.5M (Form D filed Sep 18, 2026). SEC Form D 0001640334-26-001574 (Sep 18, 2026)
  Evidence (1 event)

  • Sep 18, 2026 · SEC Form D 0001640334-26-001574
    Name of Issuer: Aqur Biosciences, Inc.; CIK: 2094075; Address: Westlake Village, CA; Submission type: D; Filing date: 2026-09-18; Industry Group: Pharmaceuticals; Date of First Sale: 2026-09-03; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 1500000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals